Satsuma Pharma’s migraine drug fails late-stage study, shares crashClinical Trials, Therapeutics“We are surprised and disappointed” that the drug did not show superiority over the placebo, Chief Executive Officer John Kollins said. Read more November 14, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/11/Migraine.jpg 650 433 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-11-14 08:44:232022-11-14 09:49:23Satsuma Pharma’s migraine drug fails late-stage study, shares crash